Page last updated: 2024-11-04

scriptaid and Multiple Myeloma

scriptaid has been researched along with Multiple Myeloma in 1 studies

scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yao, R1
Han, D1
Sun, X1
Xie, Y1
Wu, Q1
Fu, C1
Yao, Y1
Li, H1
Li, Z1
Xu, K1

Other Studies

1 other study available for scriptaid and Multiple Myeloma

ArticleYear
Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21.
    Experimental hematology, 2018, Volume: 60

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Epigenesis, Genet

2018